Machine learning is now helping researchers analyze the makeup of unfamiliar cells, which could lead to more personalized medicine in the treatment of cancer and other serious diseases.
Novartis, Sanofi and PhRMA push FDA on how to better handle complex trial designs
Several industry stakeholders are asking the FDA to streamline its processes for working with sponsors on complex and innovative designs for clinical trials. The comments